These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24391705)

  • 1. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
    Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
    PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
    Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
    Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence marker protein-30 (SMP30) deficiency impairs myocardium-induced dilation of coronary arterioles associated with reactive oxygen species.
    Mizukami H; Saitoh S; Machii H; Yamada S; Hoshino Y; Misaka T; Ishigami A; Takeishi Y
    Int J Mol Sci; 2013 Apr; 14(5):9408-23. PubMed ID: 23629672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related oxidant stress with senescence marker protein-30 deficiency plays a pivotal role in coronary artery spasm.
    Hoshino Y; Yamada S; Saitoh S; Machii H; Mizukami H; Miyata M; Misaka T; Ishigami A; Takeishi Y
    Coron Artery Dis; 2013 Mar; 24(2):110-8. PubMed ID: 23291859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Senescence Marker Protein 30 Exacerbates Cardiac Injury after Ischemia/Reperfusion.
    Kadowaki S; Shishido T; Sasaki T; Sugai T; Narumi T; Honda Y; Otaki Y; Kinoshita D; Takahashi T; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Ishigami A; Takeishi Y; Kubota I
    Int J Mol Sci; 2016 Apr; 17(4):542. PubMed ID: 27077846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
    Yu X; Cui L; Zhang Z; Zhao Q; Li S
    Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility of radiation-induced intestinal apoptosis in SMP30 KO mice.
    Goo MJ; Park JK; Hong IH; Kim AY; Lee EM; Lee EJ; Hwang M; Jeong KS
    Int J Mol Sci; 2013 May; 14(6):11084-95. PubMed ID: 23708106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
    Zhang Y; Kang YM; Tian C; Zeng Y; Jia LX; Ma X; Du J; Li HH
    PLoS One; 2011; 6(6):e21104. PubMed ID: 21738612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence marker protein-30 deficiency impairs angiogenesis under ischemia.
    Yamauchi H; Miura S; Owada T; Saitoh S; Machii H; Yamada S; Ishigami A; Takeishi Y
    Free Radic Biol Med; 2016 May; 94():66-73. PubMed ID: 26912033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
    Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
    Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
    Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.
    Naka K K; Vezyraki P; Kalaitzakis A; Zerikiotis S; Michalis L; Angelidis C
    Cell Stress Chaperones; 2014 Nov; 19(6):853-64. PubMed ID: 24748476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
    Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
    Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
    Nozaki N; Shishido T; Takeishi Y; Kubota I
    Circulation; 2004 Nov; 110(18):2869-74. PubMed ID: 15505089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion.
    Hasegawa G; Yamasaki M; Kadono M; Tanaka M; Asano M; Senmaru T; Kondo Y; Fukui M; Obayashi H; Maruyama N; Nakamura N; Ishigami A
    Endocrinology; 2010 Feb; 151(2):529-36. PubMed ID: 19934374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.